
Please try another search
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, rafoxanide, diminazene aceturate, s-methoprene, carprofen, diminazene diaceturate, ractopamine HCI, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, fenbendazole, and xylazine hydrochloride. It also provides human health pharmaceutical ingredients, including nitazoxanide and atovaquone; and intermediates and specialty chemicals comprising 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-ethyl glucamine. In addition, the company offers finished dosage forms, including diminazene aceturate granules and homidium chloride tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.
Name | Age | Since | Title |
---|---|---|---|
Dhananjay Mungale | - | 2024 | Independent Director |
Sarala Menon | - | 2021 | Non-Executive Independent Woman Director |
Dhananjay Narendra Mungale | 72 | 2024 | Independent Chairman |
Rajesh Narayan Lawande | 49 | 2005 | Whole Time Director & CFO |
Ajita Rahul Nachane | 56 | 2014 | Non Executive Woman Director |
Jayaram Sitaram | 60 | 2015 | Independent Non-Executive Director |
Rahul Jayant Nachane | 61 | 1993 | CEO, MD, Chief Ethics Counsellor & Executive Director |
Sudhir Ramchandra Deo | 70 | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review